Managing complex medication regimens: perspectives of consumers with osteoarthritis and healthcare professionals by Manias, Elizabeth et al.
The disease course of osteoarthritis isunpredictable, and symptoms can
vary daily.1 This unpredictability be-
comes even more complex when more
than one chronic condition is involved,
resulting in high utilization of healthcare
services and polypharmacy.2-4 Failure to
manage medications appropriately can
lead to inadequate symptom relief, with
associated personal, health, and econom-
ic problems.5 For example, 2.4–3.6% of
all Australian hospital admissions occur
because of inappropriate use of medica-
tions,6 while in the US, 0.8– 4.7% of
hospital admissions have been attributed
to medication-related problems.7-10
We sought to examine medication man-
agement for osteoarthritis and other chron-
ic conditions from the perspectives of
community-dwelling consumers and
healthcare professionals, using a qualita-
tive approach. A qualitative approach
can provide comprehensive understand-
ing of how consumers make decisions
about their medications.11-13 An extensive
synthesis of 37 qualitative studies of
medicine-taking practices revealed con-
sumer preference for taking as few drugs
as possible due to fear about long-term
adverse effects.11 The synthesis also
showed that previous studies involved
people’s experiences of individual drug
classes, such as antiretroviral agents, an-
tihypertensives, and psychotropic medicines. In the synthe-
sis, there was little evidence that past work addressed how
people with osteoarthritis and coexisting chronic condi-
tions manage their medications. 
Sale et al.13 conducted in-depth interviews with 19 older
consumers with osteoarthritis about their use of pain-re-
lieving medications. Consumers were reluctant to take
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RESEARCH REPORTS
BACKGROUND: Managing medications is complex, particularly for consumers with
multiple coexisting conditions for whom benefits and adverse effects are un-
predictable and health priorities may be variable. 
OBJECTIVE: To investigate perceptions of and experiences with managing drug
regimens from the perspectives of consumers with osteoarthritis and coexisting
chronic conditions and of healthcare professionals from diverse backgrounds. 
METHODS: Using an exploratory research design, focus groups were formed with
34 consumers and 19 healthcare professionals. Individual interviews were
undertaken with 3 community medical practitioners.
RESULTS: Consumers’ management of medications was explored in terms of 3
themes: administration of medications, provision of information, and the perceived
role of healthcare professionals. In general, consumers lacked understanding
regarding the reason that they were prescribed certain medications. Since all
consumer participants had at least 2 chronic conditions, they were taking many
drugs to relieve undesirable symptoms. Some consumers were unable to achieve
improved pain relief and were reluctant to take analgesics prescribed on an as -
needed basis. Healthcare professionals discussed the importance of using non-
pharmacologic measures to improve symptoms; however, consumers stated that
physicians encourage them to continue using medications, often for prolonged
periods, even when these agents are not helpful. 
CONCLUSIONS: Consumers were dissatisfied about the complexity of their medi-
cation regimens and also lacked understanding as to how to take their drugs
effectively. Dedicated time should be devoted during medical consultations to
facilitate verbal exchange of information about medications. Pharmacists must
communicate regularly with physicians about consumers’ medication needs to
help preempt any problems that may arise. Instructions need to be revised
through collaboration between physicians and pharmacists so that “as needed”
directions provide more explicit advice about when and how to use such drugs.
Future research, using large, generalizable samples, should examine trends
related to consumers’ experiences of symptomatic relief from chronic conditions
and their understandings about medications.
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analgesics and, when they did use the drugs, they took
them less frequently or at a lower dose than prescribed.
While the work of these investigators was very informa-
tive, they did not consider healthcare professionals’ per-
spectives on how consumers manage their pain-relieving
medications. No qualitative work has been undertaken in
relation to consumers with osteoarthritis and other chronic
conditions from the perspectives of consumers and health-
care professionals.
Consumers take on various positions in managing medi-
cations: passive users relinquish control, active acceptors
make a conscious decision to take medications as pre-
scribed, rejecters refuse their regimen, and active modifiers
change their regimen themselves.13 The process of medica-
tion consumption, the ways in which drug information is
given, and interdisciplinary roles of healthcare profession-
als are key influences in shaping the positions taken by
consumers in managing their medications. We sought,
therefore, to investigate these influences in consumers with
osteoarthritis and other chronic conditions.
Methods
Consumers were recruited from an ambulatory care
clinic of a metropolitan teaching hospital and an arthritis
consumer organization in Australia. Inclusion criteria were
age 18 years or older and at least 2 chronic conditions (eg,
osteoarthritis and diabetes). A purposive sampling ap-
proach was used to obtain a broad cross section of individ-
uals with different medical conditions and of various ages.
A matrix that identified each consumer’s age (older or
younger than 70 y) and types of chronic medical condi-
tions, in addition to osteoarthritis, was drawn up. This ma-
trix provided readily accessible information about the
characteristics of participating consumers and which indi-
viduals to target for future focus groups. After the matrix
was set up, consumers were chosen systematically from
the list in the matrix. For example, each time a consumer
agreed to participate in a particular focus group, we exam-
ined the individual’s demographic profile in terms of age
grouping (older or younger than 70 y) and types of chronic
conditions present in addition to osteoarthritis. Future par-
ticipants, who had demographic profiles different from
those of consumers who had already consented, were then
selected from the list and invited to participate. In this way,
each focus group was balanced with consumers of younger
and older age groupings who had chronic conditions other
than osteoarthritis (eg, hypertension, ischemic heart dis-
ease, peptic ulcer disease, hypercholesterolemia, diabetes
mellitus). 
Due to restrictions associated with work commitments,
a convenience sampling method was used to recruit health-
care professionals from inpatient and outpatient hospital
environments and from the arthritis consumer organiza-
tion. They were eligible to participate in a focus group if a
large component of their work involved care of individuals
with osteoarthritis. Community medical practitioners with
their own practices were invited for individual interviews.
Due to work constraints, they were not available to attend
a healthcare professional focus group. Recruitment strate-
gies involved providing consumers with verbal and written
information about the study while they were waiting to be
seen by a healthcare professional at the hospital or con-
sumer organization and presenting informal information
sessions to healthcare professionals at departmental meet-
ings. The study was approved by the human research
ethics committees of the hospital and university. 
Semistructured guides were used for data collection
(Table 1). Two interviewers with intensive training and
several years of experience in leading focus groups and in-
terviews conducted the sessions. A circle technique was used
to ensure that every participant’s opinion was represented in
the focus groups.14 In this technique, each participant was
asked a key question if the response had not been volun-
teered previously. This technique enabled participants to con-
tribute equally and broke any patterns of dominance. All ses-
sions lasted between 60 and 180 minutes and were audio
taped with the permission of participants. Audiotapes were
later transcribed verbatim and subjected to data analysis.
All transcripts were analyzed individually with the
“framework” approach,  consisting of 5 stages.15 Familiar-
ization required gaining an overview of the data by reading
transcripts several times. The next stage involved identify-
ing a thematic framework, which included 3 themes that
mapped onto the categories of questions asked: consump-
tion of medications, provision of information, and roles of
healthcare professionals. It also included the derivation of
subthemes. Indexing involved labeling data into manage-
able units for subsequent retrieval and exploration. Chart-
ing required a process of abstraction and synthesis where-
by transcripts were annotated with particular subthemes
associated with the 3 themes of the framework. The map-
ping and interpreting stage involved comparing and con-
trasting participants’ experiences and searching for pat-
terns from the dataset as a whole. To address rigor, 2 inves-
tigators independently conducted data analysis and
identified subthemes within the framework of 3 themes.
All investigators examined the findings for consistency
and valid interpretation. 
Results 
Thirty-four consumers participated in focus groups; 27
of these were women. The mean ± SD age of female con-
sumers was 67 ± 8.9 years and the mean ± SD age of male
consumers was 75 ± 3.6 years. In addition to osteoarthritis,
common chronic conditions included hypertension (53%),
ischemic heart disease (47%), peptic ulcer disease (32%),
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hypercholesterolemia (32%), and diabetes mellitus (32%).
Of the consumers, 44% spoke a language other than En-
glish at home. Half the consumers lived in regional areas;
the remaining 17 resided in metropolitan areas. On aver-
age, consumers were regularly taking 7 medications daily
(range 3–16). 
Nineteen healthcare professionals participated in the fo-
cus group, including 12 rheumatologists, 3 medical in-
terns, and 1 each of a hospital pharmacist, health educator,
rheumatology nurse, and consumer advocate. Three com-
munity medical practitioners participated in individual inter-
views, all of whom worked in metropolitan settings but had
previous experience in regional and rural environments.
Tables 2–4 show the themes that form the framework of
medication management examined: consumption of medi-
cations, provision of information, and perceived roles of
healthcare professionals; examples of supporting quotes
are also provided. 
CONSUMPTION OF MEDICATIONS
Three subthemes related to consumers’ drug regimens:
practical strategies, financial constraints, and complexity
of taking multiple medications (Table 2). Consumers’
strategies to help them to take their medications were gen-
erally simple and pragmatic, involving the use of inani-
mate administration aids, such as mechanical reminder
systems, dosette boxes, and glass containers. In some cas-
es, administration aids contributed to possible mismanage-
ment of the drug regimen. Examples included potential
chemical interactions from pooling all medications into
single glass containers and patients putting the lowest dose
of an as-needed agent in an administration aid during times
when a dose range was ordered. Other strategies included
social support from relatives and peers. 
Financial constraints impacted consumers’ ability to pay
for the medications. This constraint was further burdened
by the expense associated with using complementary prod-
ucts such as glucosamine. Consumers rationalized their
medication use by omitting an analgesic unless their os-
teoarthritic pain was particularly severe. Most consumers
perceived that chronic conditions such as diabetes, hyper-
tension, and ischemic heart disease had a greater impact on
their overall health than did osteoarthritis. Therefore, they
endeavored to take all drugs required for those other condi-
tions. However, 8 participants commented that they regu-
larly omitted doses in managing any of their chronic con-
ditions because of medication costs. The financial situation
of consumers was not a concern brought up by the health-
care professional focus group, although community medi-
cal practitioners acknowledged the high cost associated
with drug therapy.
Consumers highlighted the complexity of taking multi-
ple medications, which sometimes led to errors. In relation
to osteoarthritis, patients were taking different analgesic
preparations containing varying amounts of acetamino-
phen and codeine, and nonsteroidal antiinflammatory
drugs (NSAIDs), which were prescribed on an as-needed
basis. They manipulated the as-needed analgesics in differ-
ent ways by altering the dose, changing the preparations
used, or stopping a particular drug to observe its effects.
Some participants commented that they accidentally took
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Table 1. Schedules for Focus Groups and Individual Interviews
Focus Group with Healthcare Professionals and 
Focus Groups with Consumers Interviews with Community Medical Practitioners
What things help you to use the medicines that your doctor or How do you assist consumers in managing their symptoms of 
pharmacist recommends? osteoarthritis and other chronic medical conditions? 
What things prevent you or get in the way in using the medicines that What barriers affect consumers’ ability to effectively manage their 
your doctor recommends? osteoarthritis and other chronic medical conditions?
What problems do you have with medicines that are prescribed by What problems do consumers have with prescribed medications and
your doctor? What problems do you have with medicines that have over-the-counter medications?
not been prescribed by your doctor?
How do you prepare for the time you have with your doctor or How do you perceive your role in helping consumers manage their 
pharmacist about how to take your medicines? medications?
What do you do before you come to speak to your doctor or pharmacist How do you support consumers to prepare themselves for their time
about your medicines? with you?
What things do you think are important to discuss with your doctor or What resources do you provide for consumers to manage their 
pharmacist about your medicines? osteoarthritis and other chronic medical conditions?
After you have seen your doctor or pharmacist, do you feel you To what extent do consumers understand how to use their medications?
understand how to use your medicines?
What type of information do you receive in the hospital to help you to How are consumers’ medication needs coordinated in the hospital?
use your medicines? What are the gaps or barriers in how consumers’ medication needs 
are coordinated in the hospital?
What type of information do you receive in the community or outside How are consumers’ medication needs coordinated outside of the
the hospital to help you to use your medicines? hospital? What are the gaps or barriers in how consumers’ medication 
needs are coordinated in the hospital?
Do you have any ideas on how information can be improved in the What are the key issues affecting consumers’ knowledge about their
way it is made available to you? medications? How can their knowledge be improved?
excessive amounts of acetaminophen because they did not
realize it was an active ingredient in several over-the-
counter preparations. 
Consumers stated that they kept previously prescribed
medications on hand. In completing a demographic profile,
patients were asked to identify their currently prescribed
drugs and their intended purpose. Twelve indicated that they
kept these agents in case they were needed, which added fur-
ther to the complexity of taking multiple medications.
When asked about nonpharmacologic means to treat
symptoms, most consumers preferred to use only medica-
tions; 5 stated that they placed equal emphasis on drugs
and nonpharmacologic means in managing their health.
Examples of nonpharmacologic treatments included walk-
ing, tai chi, self-management programs, hydrotherapy, and
diet. Reasons for preferring to use only medications in-
cluded ease of using drugs compared with time required to
participate in nonpharmacologic treatments, lack of moti-
vation, and difficulties with transportation. Healthcare pro-
fessionals, including community medical practitioners, ad-
vocated the importance of diet and exercise as first-line
therapies for chronic disease management, with drugs con-
sidered as second-line therapies.
PROVISION OF INFORMATION 
Participants reported subthemes around dissemination
of information at medical consultations, supply of pre-
scriptions, and consumers’ perceived lack of understand-
ing about adverse effects and benefits of drugs (Table 3).
Consumers felt relatively uncomfortable speaking about
medications during medical consultations because of lack
of time to discuss issues with physicians and feelings of
embarrassment about asking for information. On the other
hand, patients felt comfortable requesting drug information
from pharmacists because they perceived that pharmacists
were readily available and listened to patients’ concerns. All
healthcare professionals commented that they provided in-
formation regularly about patients’ medications. The phar-
macist participant highlighted the problem of relying solely
on written materials, stating that he preferred to supplement
documented resources with verbal communication.
Generally, consumers lacked understanding about ad-
verse effects and benefits of their medications and ex-
pressed a desire to receive more information from health-
care professionals. Healthcare professionals conceded that
currently available written resources were often too diffi-
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Table 2. Taking Medications Theme with Subthemes and Examples of Quotesa
Theme Subthemes and Examples of Quotes
Consumption of medications Practical strategies to assist consumers with taking their medications
“I put my tablets on a plate in the kitchen each night ready for the next morning’s medications and I also put a 
plate in the lounge room with my evening medication.” (C1)
“I use a little container for the whole day. I have different tablets for different illnesses and my doctor tells me to 
take them all together, so I put them all in the one container. If the doctor has given me a range of doses, then I 
just put in the smallest dose I am supposed to have.” (C15)
“I was having trouble remembering my patches for pain and my pharmacist gave me a little reminder gadget. So I 
know if I put my patch on Thursday, I can twist the gadget and then know that my next dose is due on Saturday.” 
(C17)
Financial constraints impact ability to take medication as prescribed
“I can’t afford all the medications the doctor tells me to take so I take some of my tablets every second day. I don’t
do that with my blood pressure or diabetes, only the pain tablets, like Panadeine, and also herbal products like 
glucosamine.” (C17)
“I find having to buy so much medication is a financial burden even if each medication is cheap. When I have to 
buy 4 or 5 things a week, it all adds up.” (C11)
“Cost is a big issue for patients, and not only for medications. Many patients can’t afford to do hydrotherapy or 
see a physiotherapist or orthotist.” (CMP1)
Consumers’ reliance on taking medications
“Quite a lot of my pain medications are taken just when necessary—I have 5 like that and it is a real trap. I think 
to myself, have I had them, when I had them, and how many I had. With these tablets I need to write down when
I have them.” (C17)
“I am on about 12 different tablets, and for some I need to take them many times during the day. I find some of 
them don’t even work, I just don’t feel any different or my pain is not better, and I say this to my doctor. I say to 
him, how do I know my blood pressure or cholesterol is down? And he says, you keep trying, you got to give 
them time. But after about six months, you wonder how much more time to give them.” (C5) 
“Patients are very reluctant to make changes to their lifestyle. They want the magic tablet.” (CMP1) 
“Patients are often overweight and don’t understand the importance of diet and exercise in helping their osteoarthritis 
condition and other things like diabetes and blood pressure management.” (CMP3)
“It is important to look at the partnership involved and ask people how they manage pain and other symptoms….You 
can work out whether they need changes to their medicines or if other methods of control should be used.” (CA) 
aAbbreviations listed identify type of participant: consumers (C), consumer advocate (CA), and community medical practitioners (CMP). Numbers
were assigned for participant groups involving more than 1 individual.
cult for consumers to comprehend. The professionals
thought that regular medical consultations would provide
opportunities to resolve misunderstandings about medica-
tions. Given that consumers had at least 2 chronic conditions,
they were taking many medications to relieve symptoms,
which sometimes led to confusion about their intended pur-
pose. The specific drug classes of which consumers were un-
sure about perceived benefits included as-needed analgesics,
proton pump inhibitors, antiepileptic or antidepressant drugs
for neuropathic pain, and antihypertensive or oral hypo-
glycemic therapies (when more than one preparation from ei-
ther class had been prescribed). 
PERCEIVED ROLES OF HEALTHCARE PROFESSIONALS 
Three subthemes regarding the role of healthcare pro-
fessionals were identified: the role of the physician, the
role of the pharmacist, and the role of the nurse (Table 4).
Generally, patients perceived the physician as a prescriber
and an overseer in managing chronic illness. Although
community medical practitioners and rheumatologists be-
lieved that they had a major responsibility in supporting
consumers to use their medications effectively, this view
was not shared by many consumers.
On the other hand, consumers emphasized the pharma-
cist’s role in helping them to understand drug use and ad-
verse effects. The patients believed that, compared with
other healthcare professionals, pharmacists were best able
to support them in taking medications to suit specific
needs. Pharmacists were perceived to be the central educa-
tor about managing medications.
Nurses worked in physicians’ offices and outpatient hospi-
tal clinics; however, consumers did not perceive that nurses
played a major role in medication use. Some consumers did
Managing Complex Medication Regimens
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Table 3. Provision of Information Theme with Subthemes and Examples of Quotesa
Theme Subthemes and Examples of Quotes
Provision of information Disseminating facts about medications at the time of consultation and supply of prescription
“I used to write things down, but I found that some doctors switched off because I had a list. They must have 
thought I was a paranoid person. Some of them were experts in diverting me. I asked my questions and they 
told me that they didn’t want to spend time on them.” (C16)
“I check to see if I’m running out of medication and if I need a new prescription before going to the doctor. That’s 
my main reason for seeing him.” (C28)
“My doctor should listen more about my problems with diabetes and osteoarthritis. Sometimes I feel too nervous 
to ask him lots of questions in case he thinks I’m being difficult.” (C34)
“I have been thinking should I be taking Celebrex, as one doctor said it was okay to keep taking it, and then I saw
another doctor and he said to stop taking it. So I don’t know what to do as there is so much stuff in the media 
about heart attacks and other side effects.” (C19)
“The thing that bothers me is the side effects and doctors don’t seem to ask you about them….My pain became 
so bad that none of the normal medications—Panadol (acetaminophen) or Panadeine (acetaminophen and 
codeine combination therapy)—were making any difference, so the doctor gave me Tramadol. And with this 
tablet I had a fit. I had a fit about 45 years ago but that was just once. I went back to him and he said the tablet 
may have caused it….I feel that I shouldn’t have to remember to tell him that kind of thing. He should have looked
up my history and asked about it.” (C13)
“My pharmacist is really good. He rings up the doctor if he thinks I shouldn’t take the medication.” (C27)
“I don’t usually get much information from my specialist.” (C22)
“My doctor tells me to take the medication and gives information about side effects, but I always also ask my 
pharmacist.” (C29)
“My doctor is too busy. He just writes the prescription.” (C20)
“I give patients pamphlets and things like that, but do they read the information given to them?” (RMC8)
“I ask at each visit what medication and dosage patients are taking. I then tell them if they don’t know.” (CMP3)
“Patients often go to the side effects first with documented information, and if they see a long list they get really 
worried. It’s important to talk them through these side effects.” (P)
Perceived lack of understanding about adverse effects and benefits
“I would like to know what to do if I have a side effect.” (C32)
“With something like Panadeine Forte [acetaminophen and codeine combination therapy], I only take it when the 
pain is really bad. I can’t be confident to take it very often in case I…have an accident from getting too sleepy 
and falling over. I don’t know what else to take so I would rather grit my teeth and bear the pain.” (C17)
“I have so many tablets to take every day for my diabetes, blood pressure, depression, and osteoarthritis that I 
get confused about what they are all for. ” (C9)
“I don’t even think my tablets make any difference to my pain, so why bother taking them? I am also worried that 
if I take them too often I might get addicted to them.” (C7)
“The information currently available is complex with regard to all of the side effects and benefits of medications.” 
(RMC11)
“It is too much to ask a patient to know the side effects of a medication, so regular doctor visits are the key thing.”
(CMP2)
aAbbreviations listed identify type of participant: consumers (C), community medical practitioners (CMP), hospital pharmacist (P), and rheumatology
medical consultants (RMC). Numbers were assigned for participant groups involving more than 1 individual.
not even realize that nurses were employed in these environ-
ments. Patients suggested that, due to lack of time for medi-
cal consultation, nurses could have an enhanced role in help-
ing consumers to use their medications effectively. 
Discussion
The results of this study provide valuable insight into
the management of complex medication regimens. Two
key features differentiate our work from previous studies.
First, we sought the perspectives of various healthcare pro-
fessionals working in community and hospital settings, as
well as consumers managing their osteoarthritis at home.
Second, we recruited consumers who had at least 2 chronic
conditions. Such an approach enabled us to determine
commonalities and tensions between different healthcare
professional groups and consumers.
Despite the fact that consumers used elaborate practical
strategies to assist them in taking medications, many ex-
pressed dissatisfaction about the complexity of their drug
regimens. Healthcare professionals spoke about the impor-
tance of using nonpharmacologic measures to improve
symptoms. Nevertheless, patients indicated that, in their
experience, physicians encouraged them to continue using
medications, often for prolonged periods even though con-
sumers informed them that sometimes these products did
not work. 
The prescription instruction to take analgesics as needed
enabled consumers to manipulate therapeutic regimens to
suit their own situations. Siegal et al.16 referred to con-
sumers as “naïve scientists,” indicating that they formulate
hypotheses about their medications and then test these hy-
potheses by altering doses, switching between drugs, or
stopping them altogether to observe effects produced. This
form of medication manipulation was identified in inter-
views with people taking NSAIDs.12 In their sample, 4 out
of 41 individuals reduced their NSAID doses because they
believed that the medications were not working and 6
stopped NSAID treatment. In the current study, consumers
tested their taking of as-needed analgesics, often without un-
derstanding the active ingredients of these preparations.
They also tended to use analgesics to decrease the intensity
of unbearable pain already present, which often led to erratic
consumption. Rarely, consumers took analgesics on a regu-
lar basis to prevent pain from occurring in the first place or
to reduce pain intensity from an initial low starting point. In
an exploratory study, consumers indicated that they would
take as-needed medication only when the pain was severe.13
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Table 4. Perceived Roles of Healthcare Professionals with Subthemes and Examples of Quotesa
Theme Subthemes and Examples of Quotes
Perceived roles of health- Role of the community doctor and medical specialist as prescriber and overseer
care professionals “The doctor’s job is as a caretaker and to oversee my health needs.” (C13)
“With the specialists I see in hospital, usually they just check to see that I have enough medicines and that I am 
doing okay with them.” (C19)
“My specialist asked me the other day if I had this medicine for blood pressure before. He had just ordered it for 
me. I said that I hadn’t, and then he said it was much the same as my other blood pressure medicines and I 
should follow up with my local doctor about it.” (C29)
“My local doctor does not have any skills in advanced osteoarthritis, so I have to rely heavily on the specialist for 
that—with how the disease is coming along.” (C23)
“People with osteoarthritis and other conditions are generally managed in the community, so the primary medica-
tion role should lie with the local doctor as a starting point.” (HE)
“I work with senior medical staff to provide advice about medications.” (MI1)
“Our role is to monitor the progression of osteoarthritis and how it may be affected by other health problems con-
fronting the patient. Patients should talk to us about problems they have with their medications.” (RMC4)
“My role is in ongoing monitoring and offering support as often there is not a lot we can do in curing osteoarthri-
tis.” (CMP2)
Role of the pharmacist as central medication educator
“The pharmacist’s role is to educate about medicines as they are an expert.” (C15)
“I had a really bad side effect—I had blurriness from a blood pressure tablet. I felt sick and I was seeing things 
and it wasn’t written on the information sheet. But I could just walk in and ask my pharmacist about it.” (C2)
“Hospital and community pharmacists help to clarify any concerns that patients have about their medications, but 
this role can be enhanced by better collaboration between hospital and community pharmacists and between 
pharmacists and doctors.” (P)
Role of the nurse requires clarification
“I didn’t even know there was a nurse in the clinic.” (C18)
“There is so much waiting time in the clinic, it would be good if you could use this time to run over some issues to 
find out what nurses think.” (C33)
“Nurses…have an administrative and clerical role. They could do risk stratification by asking people about their 
medicines, weight loss, and blood pressure and then feeding that information back to the doctor in the clinic.” (RN)
aAbbreviations listed identify type of participant: consumers (C), community medical practitioners (CMP), health educator (HE), medical interns (MI),
hospital pharmacist (P), rheumatology medical consultants (RMC), and rheumatology nurse (RN). Numbers were assigned for participant groups
involving more than 1 individual.
Financial constraints of medication use were mentioned
by consumers in our study and acknowledged by commu-
nity medical practitioners as an important concern. Patients
were taking an average of 7 different drugs daily, which
led to consumers’ attempts to rationalize what medications
to purchase during times of budgetary constraint. Usually,
pain-relieving therapies and complementary products were
accorded lower priority compared with pharmacologic
treatment for other chronic conditions. Patients acknowl-
edged that because their pain was not life-threatening, they
could accept it most of the time. Financial difficulties im-
pacting medication-taking behaviors have also been re-
ported by researchers from North America.17-19 Many pre-
scribed medications in Australia are subsidized by the fed-
eral government through the Pharmaceutical Benefits
Scheme (PBS), the aim of which is to enable Australian
citizens to access necessary and cost-effective therapies.20
Despite the PBS, drug costs can still be a barrier for con-
sumers, particularly those with chronic illnesses or lower
incomes but who are not eligible for further government
concessions.21 Additional research should examine
whether medication usage is affected by the extent to
which governments subsidize medication costs, particular-
ly for vulnerable populations.
Consumers in our study regarded medical consultations
as a time to communicate openly with their physicians
about concerns they had with their medications. Unfortu-
nately, this experience was not always a positive one.
Some consumers believed that their questions were some-
times not welcomed because of perceived busyness of the
physician or fear of being labeled a “paranoid person.” On
the other hand, consumers overwhelmingly acknowledged
the support that they received from pharmacists. With in-
creasing access to healthcare information through the me-
dia and the Internet, people are more aware of available
options and are also demanding greater involvement in de-
cision making.22 It is therefore important that physicians
and pharmacists encourage consumers to demonstrate ac-
tive negotiating skills so that all parties can confidently
build a repertoire of treatment choices consistent with
goals of management.23,24 Greater collaboration between
physicians and pharmacists can also help to improve the
quality of medication information provided to con-
sumers.25,26
There are limitations to our study. Sampling included in-
dividuals from metropolitan and regional areas but did not
extend to those living in rural and remote environments.
Since only a convenience sampling approach was possible
for healthcare professional recruitment, there appears to be
an imbalance of rheumatologists participating in the
healthcare professional focus group. It would have been
useful to have representation from other healthcare profes-
sionals, including community pharmacists. Because com-
munity medical practitioners could only be interviewed in-
dividually, it is not possible to know the interactional ef-
fects of their views compared with those of other health-
care professionals. Due to the voluntary nature of partici-
pation, it is possible that views expressed related to
individuals who had an interest in managing medications.
Only community-dwelling consumers who accessed the
ambulatory care clinic or the arthritis consumer organiza-
tion were recruited. 
Conclusions
In relation to clinical implications, dedicated time
should be allocated during medical consultations to facili-
tate verbal exchange of information about medications.
Pharmacists need to communicate regularly with physi-
cians about consumers’ medication needs to help preempt
any problems that may arise. Instructions need to be re-
vised so that as-needed directions are clarified with more
explicit advice about when and how to use such drugs. Fu-
ture research could test whether availability of specific
medication information for consumers with several chron-
ic conditions can improve how they take medications. Ob-
servational studies using large, generalizable samples to
examine trends relating to consumers’ experiences of
symptomatic relief and their understanding about drugs are
needed.
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EXTRACTO
TRASFONDO: El manejo de los medicamentos es complicado,
particularmente para los consumidores con múltiples condiciones co-
existentes para quienes los beneficios y los efectos secundarios son
imprevisibibles y las prioridades de salud pueden ser variables. 
OBJETIVO: Investigar las percepciones y las experiencias relacionadas al
manejo de medicamentos desde las perspectivas de consumidores que
padecen de osteoartritis y otras condiciones crónicas co-existentes y de
profesionales de la salud con diversos trasfondos.
MÉTODOS: Se condujeron grupos de enfoque con 34 consumidores y 19
profesionales de la salud utilizando un diseño de investigación
exploratorio. Se realizaron entrevistas individuales con 3 médicos de la
comunidad.
RESULTADOS: Se exploró el manejo de medicamentos por los
consumidores en términos de 3 temas: el consumo de medicamentos, la
provisión de información, y el papel de los profesionales de la salud
percibido. En general, los consumidores carecieron de un entendimiento
con relación al por qué ciertos medicamentos les fueron prescritos a
ellos. Como todos los consumidores tenían por lo menos 2 condiciones
crónicas, estaban tomando muchos medicamentos para aliviar los
síntomas indeseables. Algunos consumidores no pudieron alcanzar una
mejoría en el alivio del dolor, y estuvieron renuentes a tomar analgésicos
prescritos en forma de según sea requerido. Los profesionales de la
salud hablaron sobre la importancia de utilizar medidas no-
farmacológicas para mejorar los síntomas; aún así, los consumidores
expresaron que los médicos los animaron a continuar usando
medicamentos, con frecuencia por períodos de tiempo prolongados, aún
en situaciones donde estos medicamentos no eran beneficiosos.
CONCLUSIONES: Los consumidores estuvieron descontentos con la
complejidad de sus régimenes de medicamentos y también carecieron
del entendimiento de cómo tomar sus medicamentos efectivamente. Se
debe dedicar un tiempo específico durante las consultas médicas para
facilitar el intercambio verbal de información sobre medicamentos. Los
farmacéuticos deben comunicarse regularmente con los médicos sobre
las necesidades de medicamentos de los consumidores para ayudar a
anticipar cualquier problema que pueda ocurrir. Las instrucciones al
consumidor necesitan ser revisadas a través de una colaboración entre
los médicos y los farmacéuticos, de tal manera que las instrucciones de
uso para medicamentos “según sea requerido” provean guías más
explícitas sobre cuándo y cómo utilizar tales medicamentos. Las
investigaciones futuras deben examinar las tendencias relacionadas a las
experiencias de los consumidores con relación al alivio sintomático de
condiciones crónicas y su entendimiento sobre medicamentos, haciendo
uso de muestras grandes que se puedan generalizar.
Brenda R Morand 
RÉSUMÉ
INTRODUCTION: La gestion de la polypharmacie est un problème
complexe, particulièrement pour les personnes souffrant de nombreuses
maladies, et chez qui les effets bénéfiques et les effets indésirables sont
difficiles à prédire et pour qui les priorités de santé peuvent être
variables.
OBJECTIFS: Évaluer la perception et les expériences de gestion des
médicaments à partir de la perspective de consommateurs atteints
d’arthrose associée à d’autres conditions de santé chroniques, et des
différents professionnels de la santé.
MÉTHODE: Un devis de recherché exploratoire comportant des groupes
de discussion ciblés regroupant 34 consommateurs et 19 professionnels
de la santé ont été utilisés pour mener cette recherche. Des entrevues
individuelles ont aussi été réalisées avec trois médecins de famille.
RÉSULTATS: La gestion des médicaments par les consommateurs a été
explorée sous trois angles : la consommation de médicaments, l’accès à
l’information, et la perception du rôle des professionnels. En général, les
consommateurs ne sont pas suffisamment informés de la raison pour
laquelle ils utilisent certains médicaments. Puisque tous les
consommateurs interrogés étaient porteurs d’au moins 2 maladies
chroniques, ils recevaient plusieurs médicaments pour en soulager les
symptômes. Quelques consommateurs étaient incapables d’atteindre un
soulagement acceptable et étaient réticents à prendre des analgésiques
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prescrits au besoin. Les professionnels de la santé ont souligné
l’importance des mesures non pharmacologiques pour améliorer les
symptômes. Malgré cela, les consommateurs affirmaient que les
médecins les encourageaient à prendre les médicaments, souvent pour
des périodes prolongées, même lorsque ces médicaments étaient perçus
comme inutiles.
CONCLUSIONES: Les consommateurs n’étaient pas satisfaits de la
complexité de leurs traitements pharmacologiques et leur
compréhension de la façon optimale d’utiliser les médicaments est
limitée. Du temps devrait être consacré à l’échange verbal d’information
sur les médicaments durant les consultations médicales. Les
pharmaciens doivent communiquer régulièrement avec les médecins
concernant les besoins pharmacologiques des consommateurs pour
prévenir tout problème pouvant survenir. Une étroite collaboration entre
le médecin et le pharmacien est requise pour que les patients puissent
gérer adéquatement une recommandation d’utilisation « au besoin » en
recevant une information plus explicite. Les recherches futures devraient
porter sur les expériences des consommateurs sur le soulagement de
maladies chroniques et leur compréhension des médicaments utilisés sur
un échantillonnage plus important.
Marc Parent
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